C2i Genomics

C2i Genomics

C2i Genomics

C2i Genomics is provides cloud-based cancer diagnostic services to pharmaceutical and diagnostic organizations.
Founded
2019
Raised
$112M
Follow us
Latest funding
$100,000,000
Venture capital - 2021
LionBird iGlobe Partners Silver Lake +7
$12,000,000
Venture capital (Series A) - 2020
Casdin Capital NFX The Mark Foundation for Cancer Research
Team Size
1–10
Employees
$100,000,000 Venture capital
TechCrunch

C2i, a genomics SaaS product to detect traces of cancer, raises $100M Series B

$12,000,000 Venture capital (Series A)
Pulse 2.0

C2i Genomics Closes $12 Million In Funding

FinSMEs

C2i Genomics Raises $12M in Series A Funding